FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

Industrial real estate in desirable locations is a terrific asset. So should Stephen Wright buy shares in a FTSE 250 REIT to ...

If you need to generate income from your investments, selecting securities or funds based on their current interest or ...

For example, the recent F share price of $9.24 represents a price-to-book ratio of 0.8 and an annual dividend yield of 6.49% ...

Dividend growth investing is a proven, low-risk strategy for building wealth. Check out my four dividend growth stock picks ...

The company's announcement that it was walking back its 2028 goals for smoke-free products warranted a closer look at its prospects.

We recently published a list of 10 Best Dividend Stocks Yielding at Least 7% According to Analysts. In this article, we are ...

But making Archer Daniels Midland even more interesting is the fact that on Wednesday, shares of ADM entered into oversold ...

Global X SuperDividend ETF offers sector diversification and a high yield. Learn why SDIV provides steady income and recovery ...

Learn the realistic investment strategy needed to earn $1,000 monthly from dividend stocks, including portfolio size requirements, stock selection tips, and expert insights from successful dividend ...

It's difficult for companies to stay at the top of their industries for long. The competition in the global economy is just ...

As a Dividend King, Kimberly-Clark has demonstrated a steadfast commitment to rewarding shareholders. With the stock trading at 16.3 times trailing earnings, a discount to its five-year average ...